Drug Discovery

ProteomeXchange Consortium – Review
Tech & Innovation ProteomeXchange Consortium – Review

The modern biological revolution is no longer written solely in the sequences of the genome but in the intricate, shifting patterns of proteins that define every breath and heartbeat we experience. For years, the scientific community struggled with a deluge of raw information produced by

Study Links Common Prenatal Drugs to Higher Autism Risk
Research & Development Study Links Common Prenatal Drugs to Higher Autism Risk

In the landscape of modern medicine, the intersection of maternal health and fetal neurodevelopment remains one of the most delicate frontiers. Ivan Kairatov, a distinguished biopharma expert with a profound background in research and development, brings a wealth of knowledge to this conversation,

How Can Targeted Peptides Revolutionize Arthritis Treatment?
Research & Development How Can Targeted Peptides Revolutionize Arthritis Treatment?

The progressive erosion of joint tissue in rheumatoid arthritis remains one of the most significant challenges in modern rheumatology, primarily because the condition often remains invisible until structural damage becomes irreversible. While current clinical protocols rely heavily on systemic

Can AI-Engineered Peptides Finally Defeat MRSA?
Research & Development Can AI-Engineered Peptides Finally Defeat MRSA?

Ivan Kairatov is a distinguished biopharma expert who has spent years at the intersection of technology and drug discovery, focusing on how computational innovation can solve the most pressing challenges in infectious disease. With a deep background in research and development, Kairatov has

St. Jude Develops New 3D Models for Pediatric Brain Tumors
Research & Development St. Jude Develops New 3D Models for Pediatric Brain Tumors

Introduction The devastating impact of central nervous system tumors on pediatric health continues to drive a relentless search for more effective therapeutic strategies that can offer hope to families facing a grim diagnosis. For decades, the complexity of the human brain and the aggressive nature

How Does Epigenetic Plasticity Drive Cancer Drug Resistance?
Research & Development How Does Epigenetic Plasticity Drive Cancer Drug Resistance?

When a patient undergoes targeted therapy, the initial results often seem nothing short of a medical miracle as tumors rapidly shrink and symptoms vanish, yet this reprieve is frequently cut short by a clandestine survival mechanism that modern science is only now beginning to fully decode. For

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later